Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 262

1.

A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women.

Giovannucci E, Pollak MN, Platz EA, Willett WC, Stampfer MJ, Majeed N, Colditz GA, Speizer FE, Hankinson SE.

Cancer Epidemiol Biomarkers Prev. 2000 Apr;9(4):345-9.

2.

Insulin-like growth factor (IGF)-I, IGF-binding protein-3 and colorectal adenomas in Japanese men.

Teramukai S, Rohan T, Lee KY, Eguchi H, Oda T, Kono S.

Jpn J Cancer Res. 2002 Nov;93(11):1187-94.

PMID:
12460458
3.

Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.

Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ.

J Natl Cancer Inst. 1999 Apr 7;91(7):620-5.

PMID:
10203281
4.

Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.

Schernhammer ES, Holly JM, Hunter DJ, Pollak MN, Hankinson SE.

Endocr Relat Cancer. 2006 Jun;13(2):583-92.

5.

Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.

Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, Rinaldi S, Zeleniuch-Jacquotte A, Shore RE, Riboli E.

J Natl Cancer Inst. 2000 Oct 4;92(19):1592-600.

PMID:
11018095
6.

Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of fenretinide.

Decensi A, Veronesi U, Miceli R, Johansson H, Mariani L, Camerini T, Di Mauro MG, Cavadini E, De Palo G, Costa A, Perloff M, Malone WF, Formelli F.

Clin Cancer Res. 2003 Oct 15;9(13):4722-9.

7.

Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.

Stattin P, Bylund A, Rinaldi S, Biessy C, D├ęchaud H, Stenman UH, Egevad L, Riboli E, Hallmans G, Kaaks R.

J Natl Cancer Inst. 2000 Dec 6;92(23):1910-7.

PMID:
11106682
8.

Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.

Chan JM, Stampfer MJ, Ma J, Gann P, Gaziano JM, Pollak M, Giovannucci E.

J Natl Cancer Inst. 2002 Jul 17;94(14):1099-106.

PMID:
12122101
9.

High-risk colorectal adenomas and serum insulin-like growth factors.

Renehan AG, Painter JE, Atkin WS, Potten CS, Shalet SM, O'Dwyer ST.

Br J Surg. 2001 Jan;88(1):107-13.

PMID:
11136321
10.

Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.

Krajcik RA, Borofsky ND, Massardo S, Orentreich N.

Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1566-73.

11.

Insulin resistance, apoptosis, and colorectal adenoma risk.

Keku TO, Lund PK, Galanko J, Simmons JG, Woosley JT, Sandler RS.

Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2076-81.

12.

Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.

Johansson H, Baglietto L, Guerrieri-Gonzaga A, Bonanni B, Mariette F, Macis D, Serrano D, Sandri MT, Decensi A.

Breast Cancer Res Treat. 2004 Nov;88(1):63-73.

PMID:
15538047
13.

Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps.

Schoen RE, Weissfeld JL, Kuller LH, Thaete FL, Evans RW, Hayes RB, Rosen CJ.

Gastroenterology. 2005 Aug;129(2):464-75.

PMID:
16083703
14.

Insulin-like growth factors and breast cancer risk in Chinese women.

Yu H, Jin F, Shu XO, Li BD, Dai Q, Cheng JR, Berkel HJ, Zheng W.

Cancer Epidemiol Biomarkers Prev. 2002 Aug;11(8):705-12.

15.

Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.

Baglietto L, English DR, Hopper JL, Morris HA, Tilley WD, Giles GG.

Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):763-8.

16.

A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. women.

Giovannucci E, Colditz GA, Stampfer MJ, Hunter D, Rosner BA, Willett WC, Speizer FE.

J Natl Cancer Inst. 1994 Feb 2;86(3):192-9.

PMID:
8283491
17.

Insulin-like growth factors and prostate cancer: a population-based case-control study in China.

Chokkalingam AP, Pollak M, Fillmore CM, Gao YT, Stanczyk FZ, Deng J, Sesterhenn IA, Mostofi FK, Fears TR, Madigan MP, Ziegler RG, Fraumeni JF Jr, Hsing AW.

Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):421-7.

18.
19.
20.

Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.

Woodson K, Tangrea JA, Pollak M, Copeland TD, Taylor PR, Virtamo J, Albanes D.

Cancer Res. 2003 Jul 15;63(14):3991-4.

Supplemental Content

Support Center